EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $75,070 | -76.1% | 83,700 | -68.5% | 0.00% | – |
Q4 2022 | $313,620 | -77.1% | 265,780 | +45.9% | 0.00% | – |
Q3 2022 | $1,371,000 | +291.7% | 182,188 | +227.7% | 0.00% | – |
Q2 2022 | $350,000 | -32.0% | 55,600 | -10.3% | 0.00% | – |
Q1 2022 | $515,000 | -16.7% | 62,000 | -47.9% | 0.00% | – |
Q4 2021 | $618,000 | +19.5% | 119,109 | +54.1% | 0.00% | – |
Q3 2021 | $517,000 | +53.9% | 77,277 | +96.1% | 0.00% | – |
Q2 2021 | $336,000 | -96.0% | 39,400 | -95.8% | 0.00% | -100.0% |
Q1 2021 | $8,353,000 | -35.8% | 943,849 | -10.8% | 0.00% | -33.3% |
Q4 2020 | $13,009,000 | +64.1% | 1,058,502 | +8.7% | 0.00% | +50.0% |
Q3 2020 | $7,928,000 | -6.5% | 973,905 | +10.3% | 0.00% | -33.3% |
Q2 2020 | $8,480,000 | +46.2% | 883,300 | +3.5% | 0.00% | 0.0% |
Q1 2020 | $5,802,000 | -10.6% | 853,282 | +96.0% | 0.00% | 0.0% |
Q4 2019 | $6,487,000 | +47.2% | 435,353 | +1.3% | 0.00% | +50.0% |
Q3 2019 | $4,407,000 | +39.1% | 429,924 | +43.9% | 0.00% | +100.0% |
Q2 2019 | $3,168,000 | – | 298,828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |